SandStar (formerly known as YI Tunnel), a Beijing, China-based AI startup which is exploring the edge of new retail, secured a Series B funding round.
58.com Inc. (NYSE: WUBA), China’s largest online market place for classifieds, received a US$300m Series B financing round for its consolidated subsidiary Zhuan Zhuan, an online used goods trading platform.
Sky9 Capital, a Beijing, China-based early-stage venture capital firm that invests in Chinese technology startups, closed a new set of funds with $440m in capital commitments.
IceKredit, Inc., a Los Angeles, CA and China-based credit risk and credit management company, raised $47m in pre-Series C funding.
Alibaba Group Holding Limited (NYSE: BABA) acquired Kaola, the import e-commerce platform of NetEase, Inc. (NASDAQ: NTES), for approximately US$2 billion.
Xiang He Capital, a China TMT focused venture capital firm, closed its second USD-denominated venture fund, at $425m.
The CareVoice, a Shangai, China-based health insurtech platform, closed an eight figure USD Series A funding.
Zenlayer, a Los Angeles, CA- and and Shanghai, China-based edge cloud services provider, raised $30m in Series B funding.
Cue Holdings Limited, a Shangai, China-based data technology company, completed its Series A round of financing.
KKR and NVC Lighting Holding Limited (Stock Code:2222) signed a Share Purchase Agreement under which KKR has agreed to set up a strategic partnership with NVC Lighting and acquire a majority interest in NVC Lighting’s China Lighting Business for a total equity value of approximately US$794m.
Toyota Motor Corporation and Didi Chuxing have expanded their collaboration in Mobility as a Service (MaaS) in China.
Warburg Pincus, the global private equity firm focused on growth investing, closed Warburg Pincus China-Southeast Asia II, L.P., at $4.25 billion.
Haoqipei, a Shangai, China-based Business-to-business (B2B) auto parts trading platform, closed US $60m in Series D financing.
GT Apeiron Therapeutics, a Shanghai, China-based biotech company utilizing technologies for drug discovery, raised $27m in funding.
Oncologie, a Boston, MA- and Shanghai, China-based oncology therapeutics company, closed an $80M Series B financing.